Monday, January 30, 2023
Support Us
Home Tags Angelini Pharma

Tag: Angelini Pharma

Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to...

0
Angelini Pharma obtains exclusive development, manufacturing and commercialization rights to OV101 (gaboxadol) for the potential treatment of Angelman syndrome in the European Union...
- Advertisement -

MOST POPULAR

- Advertisement -